CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-10 | Taub Rebecca Director | Sale 10b5-1 | −200 | $555.39 | $111K | 461,044 |
| 2025-12-10 | Taub Rebecca Director | Gift 10b5-1 | −5,455 | 455,589 | ||
| 2025-12-10 | Taub Rebecca Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −18,650 | 18,650 | ||
| 2025-12-04 | Sibold William John President and CEO | Sale | −2,400 | $575.34 | $1.4M | 150,074 |
| 2025-12-03 | Sibold William John President and CEO | Option exercise | +50,000 | 152,474 | ||
| 2025-12-03 | Sibold William John President and CEO | Option exercise · Performance Restricted Stock Units | −50,000 | 0 | ||
| 2025-12-02 | Dier Mardi EVP and CFO | Option exercise 10b5-1 | +4,173 | $251.63 | $1.1M | 14,613 |
| 2025-12-02 | Dier Mardi EVP and CFO | Sale 10b5-1 | −320 | $570.39 | $183K | 14,293 |
| 2025-12-02 | Dier Mardi EVP and CFO | Sale 10b5-1 | −410 | $571.99 | $235K | 13,883 |
| 2025-12-02 | Dier Mardi EVP and CFO | Sale 10b5-1 | −354 | $573.02 | $203K | 13,529 |
| 2025-12-02 | Dier Mardi EVP and CFO | Sale 10b5-1 | −717 | $574.00 | $412K | 12,812 |
| 2025-12-02 | Dier Mardi EVP and CFO | Sale 10b5-1 | −120 | $574.95 | $69K | 12,692 |
| 2025-12-02 | Dier Mardi EVP and CFO | Sale 10b5-1 | −240 | $576.15 | $138K | 12,452 |
| 2025-12-02 | Dier Mardi EVP and CFO | Sale 10b5-1 | −320 | $577.81 | $185K | 12,132 |
| 2025-12-02 | Dier Mardi EVP and CFO | Sale 10b5-1 | −258 | $578.83 | $149K | 11,874 |
| 2025-12-02 | Dier Mardi EVP and CFO | Sale 10b5-1 | −480 | $579.85 | $278K | 11,394 |
| 2025-12-02 | Dier Mardi EVP and CFO | Sale 10b5-1 | −240 | $585.44 | $141K | 11,154 |
| 2025-12-02 | Dier Mardi EVP and CFO | Sale 10b5-1 | −240 | $587.85 | $141K | 10,914 |
| 2025-12-02 | Dier Mardi EVP and CFO | Sale 10b5-1 | −160 | $589.65 | $94K | 10,754 |
| 2025-12-02 | Dier Mardi EVP and CFO | Sale 10b5-1 | −160 | $590.37 | $94K | 10,594 |
Page 11 of 82 · 1,629 trades